Melatonin pretreatment enhances the therapeutic effects of exogenous mitochondria against hepatic ischemia–reperfusion injury in rats through suppression of mitochondrial permeability transition
- 7 April 2016
- journal article
- Published by Wiley in Journal of Pineal Research
- Vol. 61 (1), 52-68
- https://doi.org/10.1111/jpi.12326
Abstract
We tested the hypothesis that melatonin (Mel) enhances exogenous mitochondria (Mito) treatment against rodent hepatic ischemia-reperfusion (IR) injury. In vitro study utilized three groups of hepatocytes (i.e., non-treatment, menadione, and menadione-melatonin treatment, 4.0 x 10(5) each), while in vivo study involved adult male Sprague-Dawley rats (n=40) equally divided into sham-control (SC), IR (60-min left lobe ischemia + 72-hr reperfusion), IR-Mel (melatonin at 30 min/6h/8h after reperfusion), IR-Mito (mitochondria 15000 μg/rat 30 min after reperfusion), and IR-Mel-Mito. Following menadione treatment in vitro, oxidative-stress (NOX-1/NOX-2/oxidized protein), apoptotic (cleaved caspase-3/PARP), DNA-damage (γ-H2AX/CD90/XRCC1), mitochondria-damage (cytosolic cytochrome-C) biomarkers and mitochondrial permeability transition were lower, whereas mitochondrial cytochrome-C were higher in hepatocytes with melatonin treatment compared to those without (all p<0.001). In vivo study demonstrated highest liver injury score and serum AST in IR group but lowest in SC group, higher in IR-Mito group than that in groups IR-Mel and IR-Mel-Mito, and higher in IR-Mel group than that in IR-Mel-Mito group after 72-hour reperfusion (all p<0.003). Protein expressions of inflammatory (TNF-α/NF-κB/IL-1β/MMP-9), oxidative-stress (NOX-1/NOX-2/oxidized protein), apoptotic (caspase-3/PARP/Bax), mitochondria-damage (cytosolic cytochrome-C) biomarkers displayed an identical pattern, whereas mitochondria integrity marker (mitochondrial cytochrome-C) showed an opposite pattern compared to that of liver injury score (all p<0.001) among five groups. Microscopically, expressions of apoptotic nuclei, inflammatory (MPO(+) /CD68(+) /CD14(+) cells) and DNA-damage (γ-H2AX(+) cells) biomarkers exhibited an identical pattern compared to that of liver injury score (all p<0.001) among five groups. Melatonin-supported mitochondria treatment offered additional benefit of alleviating hepatic IR injury. This article is protected by copyright. All rights reserved.Keywords
Funding Information
- Chang Gung University (CMRPG8D0661)
This publication has 31 references indexed in Scilit:
- Isolated Mitochondria Infusion Mitigates Ischemia-Reperfusion Injury of the Liver in RatsShock, 2013
- Melatonin treatment improves adipose‐derived mesenchymal stem cell therapy for acute lung ischemia–reperfusion injuryJournal of Pineal Research, 2012
- On the free radical scavenging activities of melatonin's metabolites, AFMK and AMKJournal of Pineal Research, 2012
- Systemic administration of autologous adipose-derived mesenchymal stem cells alleviates hepatic ischemia–reperfusion injury in ratsCritical Care Medicine, 2012
- Melatonin as a natural ally against oxidative stress: a physicochemical examinationJournal of Pineal Research, 2011
- Adipose-Derived Mesenchymal Stem Cell Protects Kidneys against Ischemia-Reperfusion Injury through Suppressing Oxidative Stress and Inflammatory ReactionJournal of Translational Medicine, 2011
- Melatonin protects liver against ischemia and reperfusion injury through inhibition of toll‐like receptor signaling pathwayJournal of Pineal Research, 2011
- A Randomized Controlled Trial on Pharmacological Preconditioning in Liver Surgery Using a Volatile AnestheticAnnals of Surgery, 2008
- HMGB1 release induced by liver ischemia involves Toll-like receptor 4–dependent reactive oxygen species production and calcium-mediated signalingThe Journal of Experimental Medicine, 2007
- Reactive oxygen species during ischemia-reflow injury in isolated perfused rat liver.JCI Insight, 1988